CURIvs its industry peers
A metric-by-metric comparison of CURI against SIC 7812 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURIThis | $168M#3 | — | 4.0x#2 | 2.3x#3 | 40.1%#2 | 50.3%#1 | -10.2%#3 | -15.5%#2 | — | — | — | 13.1%#1 |
| LION | $3.3B#1 | — | — | 1.3x#2 | 1.8%#4 | 45.2%#2 | 3.7%#1 | — | 35.2%#1 | — | 54.2%#1 | — |
| ANGX | $984M#2 | — | — | 3.1x#4 | 233.2%#1 | -93.1%#4 | -51.0%#4 | — | — | — | -67.5%#2 | — |
| GAIA | $32M#4 | — | 0.4x#1 | 0.3x#1 | 10.8%#3 | 14.1%#3 | -5.2%#2 | -5.3%#1 | -6.0%#2 | — | -79.0%#3 | 0.5%#2 |
Peer set: US filers sharing this company's SEC industry classification (SIC 7812). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice